Electrophysiology
L1 subspecialty spine topic for Electrophysiology (seeded from backend/data/cardiology_taxonomy.yaml).
Also called EP, AF, AFib, atrial fibrillation, arrhythmia
Sources: 12 new papers · 5 key papers · updated Oct 20, 2026
Unverified · drafted by AI from the sources cited below
Atrial fibrillation is a very common arrhythmia that mainly affects older individuals.1
Screening for atrial fibrillation is an important aspect of clinical practice.1 Smartwatches have shown potential for detecting atrial fibrillation and other arrhythmias.2 Artificial neural networks and deep neural networks are being explored and developed to detect atrial fibrillation from electrocardiograms.13 Furthermore, alternatives to standard electrocardiography are being considered for long-term continuous monitoring, as traditional skin-contact electrodes may cause discomfort overnight.4 In diabetic patients, research comparing oral medications observed that metformin monotherapy significantly reduced the risk of atrial arrhythmias compared to dipeptidyl peptidase 4 inhibitors, thiazolidinedione, or sulfonylureas.5 Aging serves as the most important independent risk factor, and biological aging affects atrial tissue.6
Contemporary treatment of atrial fibrillation has trended away from primarily rate-control strategies toward early rhythm control in selected individuals.1 Because pulmonary veins in the left atrium are common triggers, electrical isolation via ablation forms a cornerstone of invasive treatment.2 Catheter ablation is an established intervention, demonstrating lower recurrence rates and fewer hospitalizations compared to antiarrhythmic drugs.1 Emerging ablation technologies include pulsed field ablation, which produces myocardial lesions through nonthermal electroporation to potentially limit collateral damage.1 Meanwhile, cryoballoon and radiofrequency ablation remain established techniques, and hybrid approaches are also explored.1
Despite advancements, the significance of mitochondrial dysfunction in the pathogenesis of atrial fibrillation is not fully understood, though interventions improving mitochondrial health suggest a potential benefit.1 Mechanisms linking biological aging to the condition also remain incompletely elucidated.2 Machine learning may eventually help manage patients, such as by identifying recurrence risk following catheter ablation.3
Phenotyping of Arrhythmia-induced Cardiomyopathy: From Bench to Bedside and Back
Current Heart Failure Reports — Körtl T — Oct 2026
Atrial Fibrillation Burden as an Outcome in Clinical Trials
NEJM Evidence — Andrade J — Oct 2026
Atrial Fibrillation and Aging: The Role of MicroRNA Networks Across Cellular, Structural, and Electrophysiological Remodeling
Guzmán-Martín C — Oct 2026
A Fast and Generalizable Deep Neural Network for the Detection of Atrial Fibrillation
Bioengineering — Mishra H — Oct 2026
MOE-ECG: Multi-objective ensemble fusion for robust atrial fibrillation detection using electrocardiograms
Array — Peimankar A — Oct 2026
Impact of the right atrial substrate on arrhythmia recurrence following atrial fibrillation ablation
European Heart Journal — Bodagh N — Oct 2026
ID: 4566289 CONTEXT-AWARE CONTACTLESS AFIB DETECTION FROM BED-BASED BODYSEISMOGRAPHY
Heart Rhythm O2 — Zhang Y — Sep 2026
Metformin Is Associated With a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared With Sulfonylureas
Circulation Arrhythmia and Electrophysiology — Ostropolets A
58 citations · 2021 · among the most cited on Electrophysiology
Mechanisms of Atrial Fibrillation: How Our Knowledge Affects Clinical Practice
Life — Leventopoulos G
54 citations · 2023 · among the most cited on Electrophysiology
Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions
Journal of Clinical Medicine — Muszyński P
44 citations · 2021 · among the most cited on Electrophysiology
Arrhythmias Beyond Atrial Fibrillation Detection Using Smartwatches: A Systematic Review
The Anatolian Journal of Cardiology — Pay L
35 citations · 2023 · among the most cited on Electrophysiology
Atrial fibrosis and substrate based characterization in atrial fibrillation: Time to move forwards
Journal of Cardiovascular Electrophysiology — Quah J
33 citations · 2021 · among the most cited on Electrophysiology
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.